Clinical trial · Interventional
Evaluation of the Efficiency of the IsereADOM Home-care Service Package in the Prevention of Unplanned Hospitalizations of Patients With Cancer
A Randomized, Controlled, Multicenter, Prospective, Open Study Evaluating the Efficiency of the IsereADOM Home-care Service Package in the Prevention of Unplanned Hospitalizations of Patients With Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main objective of the project is to compare the effectiveness and efficiency of innovative care through the IsereADOM home-care service package versus standard care in the prevention of unplanned hospitalizations in patients with cancer treatment. In accordance with the recommendations of the French High Authority of Health (HAS), a cost-utility analysis (ACU) will be implemented
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| IsereADOM service package | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental
- description
- Patients with oncological follow up and home-care service package IsereADOM: Objects connected to patients' home (thermometer, weight scale, tensiometer +/- oximeter, glucose meter or pedometer) with graduated protocol for medical platform support. Digital linkbook (different from the medical file) accessible to the patient and the standard care actors. Referent sentinel: a field actor to coordinate the care. Preferred contact of the patient outside the center Motivational coaching: 1 to 2 axes to be defined by the investigator among the following axes (physical activity, nutrition and hydration, drug compliance, medical follow-up, chronic and moral pain, acceptance of the disease and treatments).
- interventionNames
- Other: IsereADOM service package
- type
- NO_INTERVENTION
- label
- Control
- description
- Patients with oncological follow up only
Primary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * age \> or = 18 years old at the time of signature of informed consent form * patient with solid or hematologic tumor under treatment for cancer at the time of inclusion * Patient managed in a medical emergency context in the 2 weeks prior to inclusion * Patient living in Isère department (area of coverage of experiment) * ECOG Performance index \< or = 3 * patient with a life expectancy of 6 months or more * patient with social security system * patient able to read, write and understand French * patient with signed informed consent Exclusion Criteria: * Patient included in clinical trial evaluating early stage therapeutic innovation with pharmacokinetic sampling * Patients with follow-up in Hospitalization at Home at the end of the hospitalization for inclusion * Patient without help "referent" in the entourage (spouse, family, friend ...) * Patient residing in Elderly Accommodation (EHPAD) or in any other institution for dependent persons * Patient who is homeless or living in a home that does not allow the installation of the necessary equipment * Patient with severe cognitive impairment, defined by score at Mini Mental State Examination (MMSE)\< 23/30 * Patient unable to comply (or unwilling to comply) with follow-up of the study for the duration of participation
References
Publications (0)
Data not yet available